Literature DB >> 2896315

Altered subsets of peripheral blood lymphocytes in patients with HTLV-I associated myelopathy (HAM).

Y Itoyama1, S Minato, J Kira, I Goto, H Sato, K Okochi, N Yamamoto.   

Abstract

We studied subsets of peripheral blood lymphocytes (PBL) from 12 patients with human T-lymphotropic virus type I (HTLV-I) associated myelopathy (HAM). The percent of OKT8+ cells was significantly decreased, and the percentages of OKDR+ cells and IL-2R+ cells and the ratio of OKT4+ cells to OKT8+ cells were significantly increased compared with either HTLV-I seronegative healthy adults (controls) or HTLV-I seropositive non-HAM subjects (carriers). The subsets of PBL from eight carriers showed no differences from those in controls. The patients with HAM showed significantly higher antibody titers to HTLV-I compared with carriers. These altered PBL subsets and high HTLV-I antibody titers in the patients suggest that immune functions are in an activated state in HAM.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896315     DOI: 10.1212/wnl.38.5.816

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.

Authors:  Nazli Azimi; Steven Jacobson; Yuetsu Tanaka; Lawrence Corey; Veronika Groh; Thomas Spies
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

3.  Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.

Authors:  A Ono; M Mochizuki; K Yamaguchi; N Miyata; T Watanabe
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

4.  Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.

Authors:  R B Lal; D L Rudolph; D S Schmid; M D Lairmore
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

5.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Authors:  C L Tendler; S J Greenberg; W A Blattner; A Manns; E Murphy; T Fleisher; B Hanchard; O Morgan; J D Burton; D L Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.

Authors:  T F Greten; J E Slansky; R Kubota; S S Soldan; E M Jaffee; T P Leist; D M Pardoll; S Jacobson; J P Schneck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

7.  In vivo cellular tropism of human T-cell leukemia virus type 1.

Authors:  J H Richardson; A J Edwards; J K Cruickshank; P Rudge; A G Dalgleish
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.

Authors:  Y Lunardi-Iskandar; A Gessain; V H Lam; R C Gallo
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.